MAPT and dementia: The development and application of biomarkers of beta-amyloid (Aβ) and tau in natural history studies of aging and dementia shows that Alzheimer’s disease (AD) pathology can emerge up to 30 years prior to individuals meeting any clinical criteria for dementia (Villemagne, et al., 2013).